Kura Oncology Inc. (NASDAQ:KURA) changes shares on Tuesday trading session, with a change of 1.36% or $0.23 shares. The trading starts at $16.86 and closed at $16.93 throughout the day. The trading session low price was $16.72 and day high was $17.42 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 0.41 million while its average volume is 603.89K. In other hand, the KURA market cap reached to $952.72M. While, its current target price is $24.75.
On May 29, 2020, BRIEF-Kura Oncology Reports Overall Survival Data From Phase 2 Trial Of Tipifarnib In Hras Mutant Head And Neck Squamous Cell Carcinoma. According to the news reported on Reuters, * KURA ONCOLOGY REPORTS OVERALL SURVIVAL DATA FROM PHASE 2 TRIAL OF TIPIFARNIB IN HRAS MUTANT HEAD AND NECK SQUAMOUS CELL CARCINOMA
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is down -1.38% and up 2.63% for month. Its quarterly performance was 17.45% above, while its half year performance is up 41.70%. KURA yearly performance stood at negative -6.49% and rise 24.80% for year-to-date. Current recommendation for Kura Oncology Inc. is 1.70.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. KURA EPS (TTM) for 12-month is -1.56. EPS for this year is 12.40%, while for the next year its value is -1.87. Its EPS Q/Q reached -15.80%. It has an EPS of -42.90% down for past five years and for the next five years will be up 19.93%.
Let’s take a look on the analyst recommendations on KURA for the current month and previous month. For the current month, 9 of 9 analysts recommend stock as Buy while 0 as Sell, 0 as overweight, 0 as underweight and 0 as Hold. As compared with the previous month ratings, 0 analysts participate in stock recommendation. Out of 0, 0 rated it sell, 0 rated it as Buy and 0 as Hold Ratings. On the other hand, target price ranges from $22.00 – $28.00. Average target price for KURA was reached at $24.75.
FMR, LLC, EcoR1 Capital, LLC and Blackrock Inc. are the top three holders in Kura Oncology Inc. (KURA) stock. On Mar 30, 2020, FMR, LLC has 6.81 million shares which valued 67.8 million. On Mar 30, 2020, EcoR1 Capital, LLC owned 3.51 million shares which valued at 34.94 million. On Mar 30, 2020, Blackrock Inc. has a total of 2.95 million shares which valued at 29.33 million. In the end, Blackrock Inc. have 6.49% shares outstanding of Kura Oncology Inc. (KURA) on Mar 30, 2020. The insider ownership moved to 0.10% and institutional holding shifted to 74.70%.
The company posted an EPS (TTM) of -1.56. According to the most recent quarter report on (Jun 2020), 9 analysts estimated an average EPS of -0.42, while -0.38 EPS posted a year ago period. Analyst Estimated EPS for KURA published in the report was -$0.46 – -$0.32 during the same period. Comparing with last year, the average estimated EPS was -0.38 which is higher than -0.42 which was posted for recent quarter EPS.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for KURA rise 22.80% for period of 200 days. SMA for 50 days was -0.33% which is showing red signal, while SMA-20 was -1.42%. The moving average value for Kura Oncology Inc. (KURA) is 2.83M and 7.28% for 200 and 50 days respectively.